Objetivo For the manufacture of bone gelatine a downscaled Pilot model has been developed and tested to reflect as close as possible the industrial processes and to represent the typical manufacturing conditions. Spiking crushed fresh bone with 30 I V infected mouse brain (BSE agent) and 263 K infected hamster brain (scrape agent) and processing these materials through the downscaled model to produce gelatin. Using the processed material from the whole process to determine the residual infectivity of gelatine and declaim-phosphate by bioassay. Evaluating separately the inactivation capacity on individual process steps of the finishing unit operations by spiking the industrial starting material and processing this material through these steps and measuring the remaining infectivity. In total 17 samples are prepared and submitted to bioassay. All samples are additionally tested by immunoblotting. Ámbito científico engineering and technologymechanical engineeringmanufacturing engineering Programa(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Tema(s) 1.1.1.-1. - Key action Food, Nutrition and Health Convocatoria de propuestas Data not available Régimen de financiación DEM - Demonstration contracts Coordinador DELFT GELATIN B.V. Aportación de la UE Sin datos Dirección Rotterdamseweg 270 2600 AA DELFT Países Bajos Ver en el mapa Coste total Sin datos Participantes (2) Ordenar alfabéticamente Ordenar por aportación de la UE Ampliar todo Contraer todo ID LELYSTAD - INSTITUTE FOR ANIMAL HEALTH AND SCIENCE Países Bajos Aportación de la UE Sin datos Dirección Edelhertweg 15 8219 PH LELYSTAD Ver en el mapa Coste total Sin datos INSTITUTE FOR ANIMAL HEALTH Reino Unido Aportación de la UE Sin datos Dirección Compton Laboratory, Compton RG20 7NN NEWBURY Ver en el mapa Coste total Sin datos
